The deal comes as GSK, led by chief exec Emma Walmsley (pictured) focuses on growing its pipeline to offset declining revenues.Read More
You might also be interested in reading Bitcoin Critic Calls ‘Institutional Demand’ A Myth Following Recent Price Slump.